Conversion to mycophenolate mofetil monotherapy in liver recipients: Calcineurin inhibitor levels are key.
Norero, Blanca
Conversion to mycophenolate mofetil monotherapy in liver recipients: Calcineurin inhibitor levels are key. [electronic resource] - Annals of hepatology - 94-106 p. digital
Publication Type: Journal Article
1665-2681
10.5604/16652681.1226820 doi
Aged
Calcineurin Inhibitors--administration & dosage
Chi-Square Distribution
Cyclosporine--administration & dosage
Drug Administration Schedule
Drug Monitoring--methods
Drug Therapy, Combination
Forkhead Transcription Factors--immunology
Graft Rejection--immunology
Graft Survival--drug effects
Humans
Immunosuppressive Agents--administration & dosage
Kidney--drug effects
Liver Transplantation--adverse effects
Male
Middle Aged
Multivariate Analysis
Mycophenolic Acid--administration & dosage
Odds Ratio
Prospective Studies
Risk Factors
T-Lymphocytes--immunology
Tacrolimus--administration & dosage
Time Factors
Treatment Outcome
Conversion to mycophenolate mofetil monotherapy in liver recipients: Calcineurin inhibitor levels are key. [electronic resource] - Annals of hepatology - 94-106 p. digital
Publication Type: Journal Article
1665-2681
10.5604/16652681.1226820 doi
Aged
Calcineurin Inhibitors--administration & dosage
Chi-Square Distribution
Cyclosporine--administration & dosage
Drug Administration Schedule
Drug Monitoring--methods
Drug Therapy, Combination
Forkhead Transcription Factors--immunology
Graft Rejection--immunology
Graft Survival--drug effects
Humans
Immunosuppressive Agents--administration & dosage
Kidney--drug effects
Liver Transplantation--adverse effects
Male
Middle Aged
Multivariate Analysis
Mycophenolic Acid--administration & dosage
Odds Ratio
Prospective Studies
Risk Factors
T-Lymphocytes--immunology
Tacrolimus--administration & dosage
Time Factors
Treatment Outcome